Revolution Medicines Inc

NASDAQ: RVMD
$34.92
-$0.91 (-2.5%)
Closing price April 19, 2024
Revolution Medicines is a pioneering biotech firm focused on creating innovative treatments for cancers driven by RAS mutations. With a robust pipeline of novel targeted therapies, the company is at the forefront of precision oncology. Its leading candidates, including RMC-6236, RMC-6291, and RMC-9805, are undergoing clinical trials to tackle various RAS-addicted cancers. Additionally, Revolution Medicines is exploring combination treatments to enhance efficacy. Founded in 2014 and based in Redwood City, California, the company is dedicated to transforming cancer treatment paradigms.

Wednesday's Top Analyst Upgrades and Downgrades: Broadcom, Clean Energy Fuels, Dish Network, Occidental Petroleum, Workday and More
Wednesday's top analyst upgrades and downgrades included Broadcom, Clean Energy Fuels, Dish Network, First Republic Bank, Gaming and Leisure Properties, Occidental Petroleum, Revolution Medicines,...
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: AT&T, Exxon Mobil, Hasbro, Moderna, Snap, Under Armour and More
Friday's top analyst upgrades and downgrades included AT&T, Exxon Mobil, Hasbro, Juniper Networks, Moderna, Palo Alto Networks, Snap, Teva Pharmaceutical, Under Armour and Zscaler.
Chris Lange
Published:

Top Analyst Upgrades and Downgrades: Oil E&Ps, Amex, ADT, Gilead, Logitech, PACCAR, Regions, Stamps.com, Vivint Smart Home and More
Monday's top analyst upgrades, downgrades and initiations included American Express, ADT, Gilead Sciences, Logitech, PACCAR, Regions Financial, Stamps.com and Vivint Smart Home.
Jon C. Ogg
Published: